The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors
British Journal of Pharmacology2008Vol. 154(5), pp. 1143–1149
Citations Over TimeTop 10% of 2008 papers
Daniela da Fonseca Pacheco, André Klein, Andrea de Castro Perez, Cinthia Mara da Fonseca Pacheco, Janetti N. Francischi, Igor Dimitri Gama Duarte
Abstract
Our results provide evidence for the involvement of endocannabinoids, in the peripheral antinociception induced by the mu-opioid receptor agonist morphine. The release of cannabinoids appears not to be involved in the peripheral antinociceptive effect induced by kappa- and delta-opioid receptor agonists.
Related Papers
- → A neutral CB1 receptor antagonist reduces weight gain in rat(2007)93 cited
- → The μ‐opioid receptor agonist morphine, but not agonists at δ‐ or κ‐opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors(2008)81 cited
- → Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system(2019)43 cited
- → In vitroand non‐invasivein vivoeffects of the cannabinoid‐1 receptor agonistAM841 on gastrointestinal motor function in the rat(2015)28 cited
- THEMED ISSUE: CANNABINOIDS RESEARCH PAPER Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain(2010)